{"organizations": [], "uuid": "a92c3045a41e88ef9a6e71ba06ba1390a5290a82", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-tetraphase-pharmaceuticals-elects/brief-tetraphase-pharmaceuticals-elects-christopher-watt-as-principal-financial-officer-idUSFWN1R10W9", "country": "US", "domain_rank": 408, "title": "BRIEF-Tetraphase Pharmaceuticals Elects Christopher Watt As Principal Financial Officer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T22:33:00.000+02:00", "replies_count": 0, "uuid": "a92c3045a41e88ef9a6e71ba06ba1390a5290a82"}, "author": "", "url": "https://www.reuters.com/article/brief-tetraphase-pharmaceuticals-elects/brief-tetraphase-pharmaceuticals-elects-christopher-watt-as-principal-financial-officer-idUSFWN1R10W9", "ord_in_thread": 0, "title": "BRIEF-Tetraphase Pharmaceuticals Elects Christopher Watt As Principal Financial Officer", "locations": [], "entities": {"persons": [{"name": "christopher watt", "sentiment": "negative"}, {"name": "christophe", "sentiment": "negative"}, {"name": "watt", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-tetraphase pharmaceuticals", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "tetraphase pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "watt as principal financial officer reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 19, 2018 / 8:33 PM / Updated 16 minutes ago BRIEF-Tetraphase Pharmaceuticals Elects Christopher Watt As Principal Financial Officer Reuters Staff 1 Min Read March 19 (Reuters) - Tetraphase Pharmaceuticals Inc : * TETRAPHASE PHARMACEUTICALS - BOARD ELECTED CHRISTOPHER WATT AS PRINCIPAL FINANCIAL OFFICER & PRINCIPAL ACCOUNTING OFFICER UNTIL CFO IS NAMED * TETRAPHASE SAYS WATT HAS SERVED AS SVP, FINANCE SINCE JAN. 2017 - SEC FILING Source text - bit.ly/2FLJFga Further company coverage:", "external_links": [], "published": "2018-03-19T22:33:00.000+02:00", "crawled": "2018-03-19T22:57:27.007+02:00", "highlightTitle": ""}